A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor

NCT03393416 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

BIOLOGICAL: MASCT-I
DRUG: PD1 antibody

Sponsor

HRYZ Biotech Co.

Collaborators

[object Object]